NCT05767203View on ClinicalTrials.gov

Genetic Markers and Biomarkers in Patients With Intellectual Disabilities of Genetic Origin

NARecruitingINTERVENTIONAL

Enrollment

2,000

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

September 1, 2032

Study Completion Date

December 31, 2032

Conditions

Down SyndromeIntellectual Disability

Interventions

OTHER

Biological samplings

Blood and/or skin samples

Trial Locations (1)

75015

RECRUITING

Institut Jérôme Lejeune, Paris

All Listed Sponsors

lead

Institut Jerome Lejeune

OTHER